Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase 1 2

Status

Completed 27Unknown 9Active not recruiting 9Recruiting 8Terminated 4Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Hemangioma 2Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Prednisolone × Clear all
NCT00637832 2022-01-06

Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma

University of Southampton

Phase 2 Terminated
1 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT00967226 2016-02-24

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Children's National Research Institute

Phase 2 Terminated
19 enrolled 25 charts

Hemangioma

NCT01179490 2013-03-18

Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma

SymBio Pharmaceuticals

Phase 2 Terminated
5 enrolled 30 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡